Abbott India Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: ABBOTINDIA BSE: 500488
₹27125.00
▼ -145.00 (-0.53%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
96/100
Strong
Valuation
4/100
Expensive
Momentum
86/100
Bullish

QVM read Quality in motion Quality Strong, Valuation Expensive, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹57,639 Cr
PE (TTM)
35.7
Industry median 36.1 (152 companies)
Price to Book
12.1
PEG (TTM)
3.2
Institutions holding %
9.16%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
11.0
Relative return vs Sector, qtr %
6.2
Free Cash Flow
₹1,278 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
17.13%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
11.18%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
6.29%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
17.13%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
4.33%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
2.55
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
87.06
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
23.63%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
31.88%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
31.17%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
23.87%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
41.87%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
32.51%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

6 of 7 met
  • Yes Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Return on equity is 15% or more (32.5%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

4 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.5%
Low 27015.0000 · High 27495.0000
1W return
0.7%
Low 26530.0000 · High 27850.0000
1M return
4.9%
Low 25135.0000 · High 27850.0000
52W return
-9.3%
Low 25135.0000 · High 30655.0000
Lifetime High ₹35670.0000 (June 30, 2025)
Lifetime Low ₹730.0000 (Jan. 29, 2010)

Full price history and technicals →

EMA & SMA

Bullish6
Bearish0
5D
27026.7
10D
26846.7
20D
26654.2
50D
26679.3
100D
26789.9
200D
26898.4

Delivery and volume

Day avg. delivery
55.7%
Week avg. delivery
43.4%
Month avg. delivery
54.6%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

27211.67
Pivot
First resistance27408.33
Second resistance27691.67
Third resistance27888.33
First support26928.33
Second support26731.67
Third support26448.33
Day RSI56.9
Day MFI75.4
Day MACD152.15
Day MACD signal13.11

Beta

1M0.34
3M0.44
1Y0.27
3Y0.39

Price change analysis

↑ 4.9%
Over 1 Month
LowHigh
25135.0027850.00
↑ 6.2%
Over 3 Months
LowHigh
25135.0028940.00
↑ 2.4%
Over 6 Months
LowHigh
25135.0028940.00
↓ -9.3%
Over 1 Year
LowHigh
25135.0030655.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 35.7 (own history: 33.5–52.2)
Buy Zone
Revenue (June 30, 2026)
₹1,814 Cr
Net profit (June 30, 2026)
₹429 Cr
Basic EPS (June 30, 2026)
₹201.6600

Ranks #14 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter74.99%
  • Mutual funds7.44%
  • FII/FPI0.38%
  • Other DII1.34%
  • Public15.85%

Largest holders

NameCategoryShares %Shares
ABBOTT CAPITAL INDIA LIMITEDPromoter50.4400%10719097
ABBOTT HEALTHCARE PRODUCTS LIMITEDPromoter17.6200%3744951
BRITISH COLLOIDS LIMITEDPromoter6.9200%1470000
SBI NIFTY MIDCAP 150 MOMENTUM 50 ETFPublic1.9200%407689
CANARA ROBECO MUTUAL FUNDPublic1.0700%227197

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 74.99% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 0.26% to 0.38% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 7.68% to 7.44% in Jun 2026 qtr

32 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 0 insider trades, 1 SAST, 0 pledge events →

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
17 May 2011 RELIANCE MUTUAL FUND (SCHEME : RELIANCE CAPITAL TRUSTEE CO. Bulk Buy 199,441 1437.0000 NSE
17 May 2011 ABBOTT CAPITAL INDIA LIMITED Bulk Sell 224,000 1437.9300 NSE
30 Sep 2009 ARION COMMERCIAL PVT LTD Bulk Buy 79,203 728.3500 BSE
29 Jun 2007 RELIANCE CAPITAL TRUSTEE CO LTD A C RELIANCE LONG TERM EQUIT Bulk Buy 299,750 510.0000 BSE
29 Jun 2007 HDFC TRUSTEE CO LTD A C HDFC LONG TERM EQUITY FUND Bulk Sell 305,807 510.1300 BSE
8 Jun 2006 HFDC LONG TERM EQUITY FUN Bulk Buy 130,000 485.0000 BSE
8 Jun 2006 BIRLA DIVIDEND YIELD Bulk Sell 133,926 485.1300 BSE
7 Jun 2006 BIRLA DIVIDEND YIELD PLUS Bulk Sell 100,000 504.0400 BSE
7 Jun 2006 HDFC LONG TERM EQUITY PLA Bulk Buy 100,000 504.4100 BSE
13 Jan 2006 BIRLA MUTUAL FUND Bulk Buy 343,599 717.5000 BSE

All bulk and block deals →

Last 12 months ₹525.00 per share
Dividend yield 1.94%
Ex-dateSubjectPer share (₹)Record date
24 Jul 2026 Dividend - Rs 525 Per Share & Special Dividend Rs 131 Per Share 525.0000 24 Jul 2026
25 Jul 2025 Dividend - Rs 475 Per Share 475.0000 25 Jul 2025
19 Jul 2024 Dividend - Rs 410 Per Share 410.0000 19 Jul 2024
21 Jul 2023 Dividend - Rs 180 Per Share/ Special Dividend Rs 145 Per Share 180.0000 21 Jul 2023
2 Aug 2022 Annual General Meeting/Dividend - Rs 145 Per Share/Special Dividend- 130 Per Share 145.0000 —
19 Jul 2021 Annual General Meeting/Dividend - Rs 120 Per Share Special Dividend 155 Per Share 120.0000 —
28 Aug 2020 Annual General Meeting/Dividend - Rs 107 Per Share And Special Dividend - Rs 143 Per Share 107.0000 —
13 Aug 2019 Annual General Meeting/ Final Dividend - Rs 50 Per Share/ Special Dividend - Rs 15 Per Share 50.0000 —
10 Jul 2018 Annual General Meeting / Final Dividend- Rs 50 Per Share / Special Dividend- Rs 5 Per Share 50.0000 —
10 Jul 2017 Annual General Meeting/Dividend Rs 40/- Per Share 40.0000 —

Corporate Actions

Full history (20 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Knoll Pharmaceuticals Ltd to Abbott India Ltd.
8 Jul 2016OTHER Annual General Meeting/Divided - Rs 35/- Per Share
3 Mar 2010AGMAgm/Div-Rs.17/- Per Share

All corporate actions →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Abbott India Ltd - 500488 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • High Return on Equity (32.5%)
  • Strong net profit margin (23.6%)
  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (87.1x)
  • Healthy liquidity (Current Ratio 2.55)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • PE above 35 (35.7) -- priced for continued strong execution

Single-stock futures available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.

Part of: NIFTY 500, NIFTY 500, NIFTY MIDCAP 150, NIFTY MIDCAP 150, NIFTY MNC, NIFTY MNC, NIFTY PHARMA, NIFTY PHARMA

Frequently asked questions about Abbott India Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.